Jyh-Pyng Gau, MD.

Hematology and Oncology

SPECIALTY/PRACTICE AREAS：
• Benign and malignant hematological disorders
• Anemia, thrombocytopenia and bleeding disorder, leukopenia, Lymphadenopathy, malignant lymphoma, acute and chronic leukemia, myeloma, myeloproliferative neoplasms
LANGUAGES SPOKEN：
• English
• Chinese
• Taiwanese

 

PROFESSIONAL EDUCATION：

• M.D. Taipei Medical University School of Medicine

 

ADMINSTRATIVE APPOINTMENTS：

• Attending physician, Division of Hematology and Oncology, Department of Internal Medicine, Taipei Medical University Hospital (2022/7 up to now)

 

PUBLICATIONS：

• J.P. Gau*(correspondence author), H. C. Hsu, W.K. Chau, C.H. Ho. A novel splicing acceptor mutation of the factor VIII gene producing skipping of exon 25. Ann Hematol 2003;82:175-77.
• Yu YB, Gau JP (co-first author), Liu CY, Yang MH, Chiang SC, Hsu HC, Hong YC, Hsiao LT, Liu JH, Chiou TJ, Chen PM, Lee TS, Chou LF, Tzeng CH, Chen TJ. A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system Thromb Hemost 2012;108:225
• Chen CC, Gau JP (co-first author), Chou HJ, You JY, Huang CE, Chen YY, Lung J, Chou YS, Leu YW, Lu CH, Lee KD, Tsai YH. Frequencies, clinical characteristics, and outcome of somatic CALR mutations in JAK2-unmutated essential thrombocythemia. Ann Hematol. 2014;93:2029-2036.
• Gau JP*(correspondence author), Chen CC, Chou YS, Liu CJ, Yu YB, Hsiao LT, Liu JH, Hsu HC, Chiou TJ, Chen PM, Tzeng CH. No increase of JAK2 46/1 haplotype frequency in essential thrombocythemia with CALR mutations: Functional effect of the haplotype limited to allele with JAK2V617F mutation but not CALR mutation. Blood Cells Mol Dis. 2015 Jun;55(1):36-9
• Gau JP*(correspondence author), Chen CC, Chou YS, Liu CJ, Yu YB, Hsiao LT, Liu JH, Hsu HC, Chiou TJ, Chen PM, Tzeng CH. No increase of JAK2 46/1 haplotype frequency in essential thrombocythemia with CALR mutations: Functional effect of the haplotype limited to allele with JAK2V617F mutation but not CALR mutation. Blood Cells Mol Dis. 2015;55(1):36-9
• Chen CC, You JY, Lung J, Huang CE, Chen YY, Leu YW, Ho HY, Li CP, Lu CH, Lee KD, Hsu CC, Gau JP*(correspondence author). Aberrant let7a/HMGA2 signaling activity with unique clinical phenotype in JAK2-mutated myeloproliferative neoplasms. Haematologica. 2017 Mar;102(3):509-518.
• C.F. Yang, J.P. Gau, L.T. Hsiao, C.Y Hsu. Clinical significance of blast percentage assessed by bone marrow trephine biopsy and aspirate smear of myeloid malignancies. Pathology 2021;53(6):740-745.
• Lien MY, Yeh SP, Gau JP, Wang PN, Li SS, Dai MS, Chen TC, Hsieh PY, Chiou LW, Huang WH, Liu YC; Taiwan Blood and Marrow Transplantation Registry (TBMTR); Ko BS. High rate of invasive fungal infections after non-T cell depleted haploidentical allo-HSCT even under antifungal prophylaxis. Bone Marrow Transplant. 2021 Jul;56(7):1750-1753.
• Wang HY, Yang CF, Lin CH, Hsiao LT, Ko PS, Liu YC, Chiou TJ, Chen PM, Gau JP, Liu JH, Liu CJ. Long-term outcomes of frontline intensification in primary CNS lymphoma: A real-world single-center experience. Cancer Med. 2023 Apr;12(7):8089-8101